{"sourcedb":"DevicePMAs@therightstef","sourceid":"P160048_S006","text":"Approval for the Eversense CGM System.  The device is indicated for continually measuring glucose levels in adults (age 18 and older) with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose measurements for diabetes treatment decisions. The system is intended to: 1)\tProvide real-time glucose readings; 2)\tProvide glucose trend information; and3)\tProvide alerts for the detection and prediction of episodes of low blood glucose (hypoglycemia) and high blood glucose (hyperglycemia).The system is a prescription device. Historical data from the system can be interpreted to aid in providing therapy adjustments. These adjustments should be based on patterns seen over time. The system is intended for single patient use.","project":"consensus_PMA_Age_Indications","denotations":[{"id":"T4","span":{"begin":127,"end":132},"obj":"age_end"},{"id":"T3","span":{"begin":120,"end":122},"obj":"age_start"},{"id":"T2","span":{"begin":120,"end":132},"obj":"age_range"},{"id":"T1","span":{"begin":108,"end":114},"obj":"age_category"}]}